Hypervitaminosis A and bone

Nutrition Reviews

Volumn 58, Issue 5, 2000, Pages 138-144

  Binkley, Neil ^a   Krueger, Diane ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; RETINOL INTOXICATION; REVIEW; VITAMIN INTAKE;

ANIMALIA;

EID: 0034082161     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2000.tb01848.x     Document Type: Review

References (83)

1. Avioli LV. Significance of osteoporosis: a growing international health care problem. Calcif Tissue Int 1991;49:S5-7
2. Raisz LG. Osteoporosis: current approaches and future prospects in diagnosis, pathogenesis and management. J Bone Miner Res 1999;17:79-89
3. 3 and calcium to prevent hip fractures in elderly women. New Engl J Med 1992;327:1637-42
4. Abelow BJ, Holford TR, Insogna KL. Cross-cultural association between dietary protein and hip fracture: a hypothesis. Calcif Tissue Int 1992;50:14-8
5. Hinds TS, West WL, Knight EM. Carotenoids and retinoids: a review of research, clinical, and public health applications. J Clin Pharmacol 1997;37: 551-8
6. Olson JA. Vitamin A, retinoids and carotenoids. In: Shils ME, Olson JA, Shike M, eds. Modern nutrition in health and disease, 8th ed. Philadelphia, PA: Lea and Febiger, 1994;287-307
7. Gerster H. Vitamin A - functions, dietary requirements and safety in humans. Int J Vitam Nutr Res 1997;67:71-90
8. National Research Council. Recommended dietary allowances, 10th ed. Washington, DC: National Academy Press, 1989
9. Olson JA. Recommended dietary intakes (RDI) of vitamin A in humans. Am J Clin Nutr 1987;45:704-16
10. 12. FAO Food and Nutrition Report Series 41, Rome, 1988
11. Panel on Dietary Reference Values, Department of Health. Dietary reference values for food energy and nutrients for the United Kingdom. Report on health and social subjects 41. London: HMSO, 1991
12. Maisey S, Loughridge J, Southon S, Fulcher R. Variation in food group and nutrient intake with day of the week in an elderly population. Br J Nutr 1995;73:359-73
13. Hathcock JN, Hattan DG, Jenkins MY, et al. Evaluation of vitamin A toxicity. Am J Clin Nutr 1990;52: 183-202
14. Garry PJ, Hunt WC, Brandrofchak JL, et al. Vitamin A intake and plasma retinol levels in healthy elderly men and women. Am J Clin Nutr 1987;46:989-94
15. Carroll MD, Abraham S, Dresser CM. Dietary intake source data: United States, 1976-1980. (Vital and Health Statistics Series 11 231 [DHHS Publication (PHS) 83-1681].) Hyattsville, MD: National Center for Health Statistics, 1983
16. Koplan JP, Annest JL, Layde PM, Rubin GL. Nutrient intake and supplementation in the United States (NHANES II). Am J Public Health 1986;76:287-9
17. Stewart ML, McDonald JT, Schucker RE, Henderson DP. Vitamin/mineral supplement use: a telephone survey of adults in the United States. J Am Diet Assoc 1985;85:1585-90
18. Enstrom JE, Pauling L. Mortality among health-conscious elderly Californians. Proc Natl Acad Sci U S A 1982;79:6023-7
19. Kane EK. Arctic explorations in 1853, 1854, 1855. Volume I. New York: Arno Press and the New York Times, 1971;392-3
20. Furman KI. Acute hypervitaminosis A in an adult. Am J Clin Nutr 1973;26:575-7
21. Bendich A, Langseth L. Safety of vitamin A. Am J Clin Nutr 1989;49:358-71
22. Bauernfeind JC. The safe use of vitamin A: a report of the international vitamin A consultative group. Washington, DC: Nutrition Foundation, 1980
23. Meyers DG, Maloley PA, Weeks D. Safety of antioxidant vitamins. Arch Intern Med 1996;156:925-35
24. Marcus DF, Turgeon P, Aaberg TM, et al. Optic disk findings in hypervitaminosis A. Ann Opthalmol 1985;17:397-402
25. Pearson MG, Littlewood SM, Bowden AN. Tetracycline and benign intracranial hypertension. BMJ 1981;282:568-9
26. Vollbracht R, Gilroy J. Vitamin A-induced benign intracranial hypertension. Can J Neurol Sci 1976;3: 59-61
27. Abu-Hijleh G, Padmanabhan R. Retinoic acid-induced abnormal development of hindlimb joints in the mouse. Eur J Morphol 1997;35:327-36
28. Hummler H, Hendricks AG, Nau H. Maternal toxicokinetics, metabolism and embryo exposure following a teratogenic dosing regimen with 13-cis-retinoic acid (isotretinoin) in the cynomolgus monkey. Teratology 1994;50:184-93
29. Geelen JA. Hypervitaminosis A-induced teratogenesis. Crit Rev Toxicol 1979;6:351-75
30. Werlen MW, Lammer EJ, Rosenberg L, Mitchell AA. Maternal vitamin A supplementation in relation to selected birth defects. Teratology 1990;42:497-503
31. Rothman KJ, Moore LL, Singer MR, et al. Teratogenicity of high vitamin A intakes. N Engl J Med 1995;333:1369-73
32. Wiegand UW, Hartmann S, Hummler H. Safety of vitamin A: recent results. Int J Vitam Nutr Res 1998; 68:411-6
33. Miller RK, Hendricks AG, Mills JL, et al. Periconceptional vitamin A use: how much is teratogenic? Reprod Toxicol 1998;12:75-88
34. Dolk HM, Nau H, Hummler H, Barlow SM. Dietary vitamin A and teratogenic risk: European Teratology Society discussion paper. Eur J Obstet Gynecol Reprod Biol 1999;83:31-6
35. Davies AW, Moore T. The distribution of vitamin A in the organs of the normal and hypervitaminotic rat. Biochem J 1934;28:288-95
36. Moore T, Wang YL. Hypervitaminosis A. Biochem J 1945;39:222-8
37. Leelaprute V, Boonpucknavig V, Bhamarapravati N, Weerapradist W. Hypervitaminosis A in rats. Arch Pathol 1973;96:5-9
38. Wolbach B. Vitamin A deficiency and excess in relation to skeletal growth. J Bone Joint Surg Br 1947;29:171-92
39. Maddock CL, Wolbach SB, Maddock S. Hypervitaminosis A in the dog. J Nutr 1949;39:117-37
40. Takeuchi T, Dedi J, Haga Y, et al. Effect of vitamin A compounds on bone deformity in larval Japanese flounder. Aquaculture 1998;169:155-65
41. Coates JW, Holbek NE, Beames RM, et al. Gastric ulceration and suspected vitamin A toxicosis in grower pigs fed fish silage. Can Vet J 1998;39:167-70
42. Frankel TL, Seshadri MS, McDowall DB, Cornish CJ. Hypervitaminosis A and calcium-regulating hormones in the rat. J Nutr 1986;116:578-87
43. Hough S, Avioli LV, Muir H, et al. Effects of hypervitaminosis A on the bone and mineral metabolism of the rat. Endocrinology 1988;122:2933-9
44. Kodaka T, Takaki H, Soeta S, et al. Local disappearance of epiphyseal growth plates in rats with hypervitaminosis A. J Vet Med Sci 1998;60:815-21
45. Josepha HW. Hypervitaminosis and carotenemia. Am J Dis Child 1944;67:33-43
46. Toomey JA, Morissette RA. Hypervitaminosis A. Am J Dis Child 1947;73:473-81
47. Gerber A, Raab AP, Sobel AE. Vitamin A poisoning in adults. Am J Med 1954;16:729-45
48. Jowsey J, Riggs BL. Bone changes in a patient with hypervitaminosis A. J Clin Endocrinol Metab 1968;28:1833-5
49. Frame B, Jackson CE, Reynolds WA, Umphrey JE. Hypercalcemia and skeletal effects in chronic hypervitaminosis A. Ann Intern Med 1974;80:44-8
50. Patel P, Hanning RM, Atkinson SA, et al. Intoxication from vitamin A in an asthmatic child. Can Med Assoc J 1988;139:755-6
51. Katz CM, Tzagournis M. Chronic adult hypervitaminosis A with hypercalcemia. Metabolism 1972; 21:1171-6
52. Ragavan VV, Smith JE, Bilezekian JP. Vitamin A toxicity and hypercalcemia. Am J Med Sci 1982;283: 161-4
53. Horman KJ, Milne FJ, Schmidt C. Acne, hypervitaminosis A and hypercalcemia. S Afr Med J 1978;54: 579-80
54. Stewart AF. Miscellaneous causes of hypercalcemia. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism, 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins, 1999;217
55. Sowers MR, Wallace RB, Lemke JH. Correlates of mid-radius bone density among postmenopausal women: a community study. Am J Clin Nutr 1985;41:1045-53
56. Sowers MR, Wallace RB. Retinol, supplemental vitamin A and bone status. J Clin Epidemiol 1990;43:693-9
57. Yano K, Heilbrun LK, Wasnich RD, et al. The relationship between diet and bone mineral content of multiple skeletal sites in elderly Japanese-American men and women living in Hawaii. Am J Clin Nutr 1985;42:877-88
58. Freudenheim JL, Johnson NE, Smith EL Relationships between usual nutrient intake and bone-mineral content of women 35-65 years of age: longitudinal and cross-sectional analysis. Am J Clin Nutr 1986;44:863-76
59. Melhus H, Michaelsson K, Kindmark A, et al. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med 1998;129:770-8
60. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. The study of Osteoporotic Fractures Research Group. Lancet 1993;341:72-5
61. Euronut SENECA investigators. Intake of vitamins and minerals. Eur J Clin Nutr 1991;45(suppl 3): 121-38
62. Ortonne JP. Oral isotretinoin treatment policy. Dermatology 1997;195(suppl 1):34-40
63. Layton AM. Long-term safety and efficacy of oral isotretinoin in less severe acne. Retinoids Today Tomorrow 1996;43:6-7
64. Glover MT, Peters AM, Atherton DJ. Surveillance for skeletal toxicity of children treated with etretinate. Br J Dermatol 1987;116:609-14
65. Margolis DJ, Attie M, Leyden JJ. Effects of isotretinoin on bone mineralization during routine therapy with isotretinoin for acne vulgaris. Arch Dermatol 1996;132:769-74
66. McGuire J, Lawson JP. Skeletal changes associated with chronic isotretinoin and etretinate administration. Dermatologica 1987;175(suppl 1):169-81
67. Halkier-Sørensen L, Andresen J. A retrospective study of bone changes in adults treated with etretinate. J Am Acad Dermatol 1989;20:83-7
68. DiGiovanna JJ, Sollitto RB, Abangan DL, et al. Osteoporosis is a toxic effect of long-term etretinate therapy. Arch Dermatol 1995;131:1263-7
69. Kindmark A, Rollman O, Mallmin H, et al. Oral isotretinoin therapy in severe acne induces transient suppression of biochemical markers of bone turnover and calcium homeostasis. Acta Derm Venereol (Stockh) 1998;78:266-9
70. Okada N, Nomura M, Morimoto S, et al. Bone mineral density of the lumbar spine in psoriatic patients with long-term etretinate therapy. J Dermatol 1994;21:308-11
71. Akiyama H, Nakamura N, Nagasaka S, et al. Hypercalcemia due to all-trans-retinoic acid. Lancet 1992;339:308-9
72. Grisson LE, Griffin GC, Mandell GA. Hypervitaminosis A as a complication of treatment for neuroblastoma. Pediatr Radiol 1996;26:200-2
73. Decensi A, Torrisi R, Gozza A, et al. Effect of fenretinide on bone mineral density and metabolism in women with early breast cancer. Breast Cancer Res Treat 1999;53:145-51
74. Napoli JL. Interactions of retinoid binding proteins and enzymes in retinoid metabolism. Biochim Biophys Acta 1999;1140:139-62
75. Fell HB, Mellanby E. The effect of hypervitaminosis A on embryonic limb-bones cultivated in vitro. J Physiol 1952;116:320-49
76. Scheven BAA, Hamilton NJ. Retinoic acid and 1,25-dihydroxyvitamin D3 stimulate osteoclast formation by different mechanisms. Bone 1990;11:53-9
77. Oreffo ROC, Teti A, Triffitt JT, et al. Effect of vitamin A on bone resorption: evidence for direct stimulation of isolated chicken osteoclasts by retinol and retinoic acid. J Bone Miner Res 1988;3:203-9
78. Saneshige S, Mano H, Tezuka K, et al. Retinoic acid directly stimulates osteoclastic bone resorption and gene expression of cathepsin K/OC-2. Biochem J 1995;309:721-4
79. Dickson I, Walls J. Vitamin A and bone formation: effects of an excess of retinol on bone collagen synthesis in vitro. Biochem J 1985;226:789-95
80. Ng KW, Livesey SA, Collier F, et al. Effect of retinoids on the growth, ultrastructure, and cytoskeletal structures of malignant rat osteoblasts. Cancer Res 1985;45:5106-13
81. Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987;330:444-50
82. Kindmark A, Torma H, Johansson AG, et al. Reverse transcription-polymerase chain reaction assay demonstrates that the 9-cis-retinoic acid receptor is expressed in human osteoblasts. Biochem Biophys Res Commun 1993;192:1367-72
83. Harada H, Miki R, Masushige S, Kato S. Gene expression of retinoic acid receptors, retinoid-X receptors, and cellular retinol-binding protein I in bone and its regulation by vitamin A. Endocrinology 1995;136:5329-35